CClinicalTrials.gg
Active, not recruitingNCT05603468Updated Feb 9, 2026

Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair

A Phase 4 interventional study of platelet rich plasma and Corticosteroid in Tendinopathy, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Active, not recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
387
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Prospective, multicenter, randomized, single-blinded, parallel group,placebo-controlled,three-group establishment of specific treatment regimen for subtypes of tendinopathy

Read the detailed description

This clinical trial uses machine learning to match molecular and clinical features,so as to establish a "rapid recognition system of tendinopathy subtypes" and compares the clinical effects of corticosteroid,platelet rich plasma or placebo on different subtypes of tendinopathy.

02

Conditions studied

  • Tendinopathy

Browse trials for

Keywords

  • Tendinopathy
  • Platelet Rich Plasma
03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

This study's planned enrollment of 387 is above the median of 50 across 339 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Rotator cuff tears were diagnosis by magnetic resonance imaging or arthroscopy
  • Surgical intervention of rotator cuff tears was proposed.
  • Simple full-layer tear of supraspinatus tendon.
  • Patients give informed consent, and sign the informed consent form, and the process must meet the requirements of GCP

Exclusion criteria

Exclusion Criteria:

  • Patients with rotator cuff injuries involving infraspinatus, subscapularis, and teres minor tendon injuries
  • Patients platelet concentration is lower than 100×109
  • Patients have other shoulder diseases, including osteoarthritis, cervical spondylosis, etc.patients have inflammatory diseases, including rheumatoid arthritis, fibromyalgia, rheumatic polymyalgia, etc.patients have received injection treatment within 3 months.
  • Patients have participated in clinical trials or are conducting other clinical trials within 3 months before screening.
  • Patients have severe primary cardiovascular disease, lung disease, endocrine and metabolic disease or serious diseases that affect their survival, such as tumor or AIDS, the researchers believe that it is not suitable to be selected.
  • Patients have severe liver, kidney and hematological lesions, such as kidney function exceeding the upper limit of normal value and liver function exceeding 2 times the upper limit of normal value.
  • Patients have viral hepatitis, infectious diseases, severe abnormalities in blood coagulation and other diseases that the researchers consider unsuitable for surgery.
  • Women who are pregnant or lactating, or who plan to conceive during follow-up, those who are positive for human chorionic gonadotropin before sampling; menstrual women should wait for surgery after the end of menstruation.
  • Patients have severe neurological and mental disorders.
  • Patients suspect or do have a history of alcohol or drug abuse.
  • Patients have height body mass index (BMI) > 30.
  • Patients have tendon disease caused by systemic immune or other diseases, and patients with diseases or symptoms that may affect pain or function scores.
  • Patients have coagulation disorders caused by any other acute or chronic disease.
  • MRI detection of contraindications. Include, but are not limited to: installation of pacemakers, defibrillators, cardiac stents, artificial heart valves, metal clips after aneurysm surgery, drug infusion devices implanted in the body, any electronic devices implanted in the body (nerve stimulators, bone growth stimulators), endovascular embolization steel rings, filters, ECG recording monitors, metal sutures, shrapnel or iron particles in the body, fixation of steel plates and nails after fracture surgery, Cochlear implant, middle ear graft, intraocular metal foreign body, etc. Claustrophobia, critically ill patients, etc.
  • Refer to the April 2008 edition of the Law of the people's Republic of China on the Protection of disabled Persons, patients belong to the subjects of legal disabled persons
  • Other situations in which the researchers judged that the subjects were not suitable to participate.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
387 participants (estimated)

Study arms

  • Experimental
    Platelet Rich Plasma group

    patients rejected with platelet rich plasma

    Drug: platelet rich plasma

  • Active comparator
    Corticosteroid group

    patients rejected with corticosteroid

    Drug: Corticosteroid

  • Placebo comparator
    Normal saline group

    patients rejected with normal saline

    Drug: Normal saline

Interventions

  • Drugplatelet rich plasma

    Platelet rich plasma group: after the surgery of rotator arthroscopic rotator cuff repair, 3ml PRP (LongTai Biological Company) was injected into the rotator cuff tear under the rotator arthroscope for a time. PRP production process: before anesthesia, 20ml arterial blood was drawn and injected into the PRP tube. The blood was fully oscillated in the tube, and then placed in a centrifuge with 1500g for 9min to remove excess plasma and make 5ml PRP. 3ml is used for injection and 2ml is used for quality control.

  • DrugCorticosteroid

    Corticosteroid group: after the surgery of rotator cuff repair under arthroscopy, 1mL prednisone (MSD) + 2mL sodium hyaluronate (biochemical Industry Co., Ltd.) was injected under arthroscopy.

  • DrugNormal saline

    Normal saline

06

What researchers measure

Primary outcomes

  1. Oxford Shoulder Score (OSS)

    The Oxford Shoulder Score (OSS) consists of 12 questions with five options each. The light to heavy lines were assigned 1, 2, 3, 4 and 5 points respectively. So the total score is between 12 and 60. A score of 12 represents perfectly normal shoulder function and a score of 60 represents the most severe difficulty in shoulder function.

    Time frame: 6months after surgery

Secondary outcomes

  1. Oxford Shoulder Score (OSS)

    The Oxford Shoulder Score (OSS) consists of 12 questions with five options each. The light to heavy lines were assigned 1, 2, 3, 4 and 5 points respectively. So the total score is between 12 and 60. A score of 12 represents perfectly

    Time frame: 3 months, 1year, and 2years after surgery

  2. Constant-Mulery score(CMS)

    The Constant-Mulery score mainly includes 8 aspects related to your shoulder in the past 4 weeks. The proportion of subjective and objective components in the Constant-Mulery score is 35 points/65 points. A total of 100 points.The subjective part of the score includes the score of pain degree and the score of impact on daily life. 35 points in total.The objective part of the score includes the score of shoulder range of motion and strength. 65 points in total.

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  3. Fear-avoidance belief questionnaire(FABQ)

    The FABQ is a self-assessment scale with 16 options. Each option has 0\~6 points and 7 grades (from extremely disagreeable to extremely agreed). "0" means completely disagreed, "6" means completely agreed, and "1\~5" means not sure. The higher the score, the more inclined to fully agree.

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  4. Insomnia Severity Index(ISI)

    The scale is a simple tool for screening insomnia, including 7 items, which are used to evaluate the nature and symptoms of sleep disorders of subjects.

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  5. Hospital Anxiety and Depression Scale(HADS)

    HADS is a self-assessment scale, including two subscales, HADS-A and HADS-D, with a total of 14 items, including 7 items for anxiety (A) and 7 items for depression (D). Each item is scored at four levels according to the frequency of symptoms in the past month. Each item is scored at 0-3 points in four levels. The higher the score, the more serious the anxiety or depression.

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  6. SF-36

    SF-36 is a concise health questionnaire developed by the Boston Institute of Health, which is widely used in the measurement of the quality of life of the general population, the evaluation of clinical trials and the evaluation of health policies. SF-36 is used to assess physiological function, physiological function, physical pain, general health, energy, social function, emotional function and mental health, which are classified into "physical health" and "mental health"

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  7. Visual analogue scale(VAS)

    Draw a 10cm horizontal line on the paper. One end of the line is "0", indicating no pain; the other end is "10", indicating severe pain; The middle represents different degrees of pain; Let the patient draw a mark on the horizontal line according to their feelings to indicate the degree of pain.

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  8. range of motion

    Measure the patient's flexion, abduction, internal rotation and external rotation angle

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  9. muscle strength

    Use dynamometer to evaluate patient's forward bending, abduction, external rotation and internal rotation strength.

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  10. retear rate

    Proportion of the total number of people with retearing after arthroscopic rotator cuff repair

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  11. Acromiohumeral distance

    Measurement of acromiohumeral distance based on x-ray

    Time frame: 3 months, 6months, 1year, and 2years after surgery

  12. Signal to noise ratio of tendon in MRI

    Measurement of Signal to Noise Ratio of Tendon in MRI based on software

    Time frame: 3 months, 6months, 1year, and 2years after surgery

07

Study locations

1 site
  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Hangzhou, Zhejiang 310058, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05603468
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible party
Sponsor
First posted
Nov 2, 2022
Start date
Dec 15, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Feb 9, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion